Researchers at MIT had an extra reason to celebrate for the new year: technological breakthrough on an ingestible pill that can be regulated by Bluetooth. The pill will be able to send drugs to your body, sense changes within your body, or both. The capsule only can stay in the patients stomach for at least a month and can be controlled by your cellphone. The capsule will be able to administer drugs to treat a variety of diseases and sense changes in the body such as infections and allergic reaction and administer the correct dosage of medication in response to the change.
The device will be able to communicate with other implantable devices and send data to patient and/or doctors cellphone, most useful for long-term delivery of drugs that have to be injected otherwise and patients who require rigorous treatment procedures such as in HIV and malaria cases. Another usage for this “electronic pill” is the monitoring of patients taking chemotherapy or immunosuppressive drugs for infection.
Although the most recent variation is powered by a small battery made of silver oxide, the researchers are still analyzing the possibility of using other power sources such as an external antenna or stomach acid. Currently the device is able to assess the vital signs of patients ( e.g. heart rate and breathing) as well as monitoring patient temperature. The researchers are hoping to incorporate more forms of sensors for the “electronic pills”. They estimate that around two years from no they may be able to start testing ingestible sensors in human patients.
Check Back Often For More Insight!
Cheyann is a reporter at GoldenGOAT Articles that specializes in lifestyle, innovation, environment and the health care industry. After graduating high school with high honors in science and mathematics, she went on to college to specialize in biomedical engineering.